Miln James sold $369K of XMTR

Miln James (Chief Financial Officer) sold 3,892 shares of Xometry, Inc. (XMTR) at an average of $94.74 ($90.76–$98.51, $0.37M total) across 9 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Miln James
Published Jul 6, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but the disclosure alone typically has limited impact absent accompanying fundamental news.

02

Market read

A routine insider-sale Form 4 for XMTR filed today; likely low incremental trading signal.

03

What to watch

The article does not state whether the CFO’s remaining holdings changed materially beyond the post-transaction share count, nor does it provide context on prior sales frequency or total compensation-driven selling.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-06 (after the sale dates 2026-07-01 to 2026-07-02).

Background

The article is an SEC Form 4 insider transaction: CFO Miln James executed open-market sales of XMTR shares under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

Xometry CFO Miln James sold $368,733 of XMTR shares via an open-market sale under a pre-arranged 10b5-1 plan (Form 4 filed today).

Expected impact

Low near-term impact; any reaction is likely muted and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.

Market effects

No direct sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if paired with other negative signals (not present here).

Key entities

  • Xometry, Inc.

    Company whose shares were sold by its CFO under a 10b5-1 plan (XMTR).

  • Miln James

    Chief Financial Officer who sold 3,892 shares across nine trades.

  • Rule 10b5-1 plan

    Pre-arranged plan indicating the sales were scheduled in advance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Xometry (XMTR) Q3 2026 Earnings Call Transcript

Xometry (XMTR) reported Q3 2026 revenue of $252M, up 40% YoY, with record gross margin and GAAP profitability. The company raised its full-year outlook, citing strong growth and AI-driven marketplace optimizations. It also announced a partnership with Siemens for integration into Designcenter, expected to launch in Q1 2027.

$XMTRMed

Xometry Inc (XMTR) Q3 2026 Earnings Call Highlights: Record Revenue, First GAAP Profit

Xometry Inc (XMTR) reported Q3 2026 revenue of $252M, up 40% YoY, and its first GAAP profit of $1.9M. Marketplace revenue grew 43% YoY, while services revenue lagged at 2% growth. The company raised its full-year 2026 revenue growth outlook to 37% and adjusted EBITDA guidance to $68-68.5M. Active buyers increased 20% YoY to over 93,000, but Q4 revenue growth is expected to decelerate to 32-33% YoY. Xometry continues to invest heavily in growth initiatives, with Q3 cash CapEx of $15M.

$XMTRHighAI 9/10

Why is Xometry stock surging today?

Xometry (XMTR) stock surged 15.8% after reporting Q3 revenue of $252.4M, up 40% YoY, and adjusted EPS of $0.28, beating estimates. The company achieved its first GAAP net income of $1.9M. Marketplace revenue grew 43%, and active buyers increased 20%. Xometry raised its full-year outlook and guided Q4 revenue to $254–$256M. The stock reached a new 52-week high of $117.50.